4[3]Martha Mitch Funnell. Robert M. Anderson. The problem with compliance in diabetes. JAMA ,2000,284 ( 13 ): 1709.
5[6]Tebbi CK. Treatment compliance in childhood and adolescence. Cancer, 1993,71:3441.
6[7]Vaur L, Vaisse B, Genes N, et al. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large - scale trial. Am J Hypertens, 1999,12 (4 Pt 1 ): 374-380.
7[8]Andrejak M,Genes N,Vaur L,et al. Electronic pill boxes in the evaluation of antihypertensive treatment compliance:Comparison of once daily versus twice daily regimen. Am J Hypertens,2000,13 (2) :184-190.
8[9]Van Berge Henegouwen MT. Van Driel HF. Kasteleijn Nolst Trenite DG. A patient diary as a tool to improve medicine compliance. PharmWorldSci. 1999, 21 (1): 21 -24.
9[10]Spooren D,Van Heeringen C,Jannes C. Strategies to increase compliance with outpatient aftercare among patients referred to a psychiatric emergency department: a multicentre controlled intervention study.Psychol Med, 1998,28 (4) :949 - 956.
2KElIebaek E, Hetedt J. Optimizing antiemetic therapy in multiple - day and muhiple cycles of chemotherapy[ J]. Curt Opin Support Palliat Care. ,2008,2 ( l ) :28 - 34.
3Molassiotis A, Saunders MP, Valle J, et al. A prospective obser- vational study of chemotherapy - related nausea and vomiting in routine practice in a UK cancer centre [ J]. Support Care Canc,2008,16(2) :201 -208.
4Aapro MS, Schmoll H J, Jahn F, et al. Review of the efficacy of aprepitant for the prevention of chemotherapy - induced nausea and vomiting in a range of tumor types[J]. Cancer treatment reviews, 2013,39(1) :113 - 117.
5Mertens WC, Higby DJ, Brown D, et al. Improving the care of patients with regard to chemotherapy - induced nausea and emesis : the effect of feedback to clinicians on adherence to antiemetic pre- scribing guidelines[ J]. J Clin Oneol, 2003 ;21 (7) : 1373 - 1378.
6Caracuel F, Bauos U, Herrera MD, et al. Influence of pharma- ceutical care on the delayed ernesis associated with chemotherapy [J]. Int J Clin Pharna,2014, 36(2) :287 -290.
7Liekweg A, Westfeld M, Braun M, et al. Pharmaceutical care for patients with breast and ovarian cancer[ J]. Support Care Cancer, 2012,20 ( 11 ) :2669 - 2677.
8Wong SF, Bounthavong M, Nguyen C, et al. Implementation and preliminary outcomes of a comprehensive oral chemotherapy man- agement clinic[J]. Am J Health Syst Pharm. ,2014,71 (11) :960 - 965.
